Small-Molecule Inhibitors of Protein Geranylgeranyltransferase Type I
摘要:
Small molecules that inhibit the geranylgeranylation of K-Ras4B and RhoA by protein geranylgeranyltransferase type I (GGTase-I) were identified from chemical genetic screens of heterocycles synthesized through phosphine catalysis of allenes. To further improve the efficacy of the GGTase-I inhibitors (GGTIs), 4288 related compounds bearing core dihydropyrrole/pyrrolidine and tetrahydropyridine/piperidine scaffolds were synthesized on SynPhase lanterns in a split-pool manner through phosphine-catalyzed [3 + 2] and [4 + 2] annulations of resin-bound allenoates. Testing of the 4288 analogues resulted in several GGTIs exhibiting submicromolar IC50 values. Because proteins such as Ras and Rho GTPases are implicated in oncogenesis and metastasis, these GGTIs might ultimately lead to the development of novel antitumor therapeutics.
The present invention provides small molecules for endothelial cell activation and compositions thereof and methods of making and using the same
本发明提供了用于内皮细胞活化的小分子及其组合物,以及制备和使用这些小分子的方法。
Small molecules for endothelial cell activation
申请人:Cruz Daniel
公开号:US10197557B2
公开(公告)日:2019-02-05
The present invention provides small molecules for endothelial cell activation and compositions thereof and methods of making and using the same.
本发明提供了用于内皮细胞活化的小分子及其组合物以及制造和使用方法。
INHIBITORS OF PROTEIN PRENYLTRANSFERASES
申请人:Tamanoi Fuyuhiko
公开号:US20100063114A1
公开(公告)日:2010-03-11
The present invention is directed to novel compounds. These compounds can be useful in inhibiting the activity of GGTase I. The compounds can also be used as anti-cancer therapeutics including as part of methods for treating cancer, in assays, and in kits.
Small Molecules For Endothelial Cell Activation
申请人:Cruz Daniel
公开号:US20130310417A1
公开(公告)日:2013-11-21
The present invention provides small molecules for endothelial cell activation and compositions thereof and methods of making and using the same.